FDA weighs multiple views regarding the Biologics Price Competition and Innovation Act.
Chad Landmon
Advertisement
Articles by Chad Landmon
Advertisement
Latest Updated Articles
- Advocating for Biosimilar Approval Standards Under BPCI
Published: September 1st 2011 | Updated:
Advertisement
Advertisement
